Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2008.18.6965 on January 21 2009

Journal of Clinical Oncology, Vol 27, No 7 (March 1), 2009: pp. 1062-1068
© 2009 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vinh-Hung, V.
Right arrow Articles by Bouchardy, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vinh-Hung, V.
Right arrow Articles by Bouchardy, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Lymph Node Ratio as an Alternative to pN Staging in Node-Positive Breast Cancer

Vincent Vinh-Hung, Helena M. Verkooijen, Gerald Fioretta, Isabelle Neyroud-Caspar, Elisabetta Rapiti, Georges Vlastos, Carole Deglise, Massimo Usel, Jean-Michel Lutz, Christine Bouchardy

From the Geneva Cancer Registry, Institute for Social and Preventive Medicine, Geneva University; Senology and Surgical Gynecologic Oncology Unit, Department of Gynecology and Obstetrics, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Universitair Ziekenhuis Brussel, Jette, Belgium; and Department of Community Occupational and Family Medicine, National University of Singapore, Singapore.

Corresponding author: Vincent Vinh-Hung, MD, PhD, Oncology Center, Universitair Ziekenhuis Brussel, 101 Laarbeeklaan, 1090 Jette, Belgium; e-mail: conrvhgv{at}uzbrussel.be.

Purpose In the current pTNM classification system, nodal status of breast cancer is based on the number of involved lymph nodes and does not account for the total number of lymph nodes removed. In this study, we assessed the prognostic value of the lymph node ratio (LNR; ie, ratio of positive over excised lymph nodes) as compared with pN staging and determined its optimal cutoff points.

Patients and Methods From the Geneva Cancer Registry, we identified all women diagnosed with node-positive breast cancer between 1980 and 2004 (n = 1,829). The prognostic value of LNRs was calculated for values ranging from 0.05 to 0.95 by Cox regression analysis and validated by bootstrapping. Based on maximum likelihood, we identified cutoff points classifying women into low-, intermediate-, and high-risk LNR groups.

Results Optimal cutoff points classified patients into low- (≤ 0.20), intermediate- (> 0.20 and ≤ 0.65), and high-risk (> 0.65) LNR groups, corresponding to 10-year disease-specific survival rates of 75%, 63%, and 40%, and adjusted mortality risks of 1 (reference), 1.78 (95% CI, 1.46 to 2.18), and 3.21 (95% CI, 2.54 to 4.06), respectively. In contrast to LNR risk categories, survival curves of pN2 and pN3 crossed after 15 years, and their adjusted mortality risks showed overlapping CIs: 2.07 (95% CI, 1.69 to 2.53) and 2.84 (95% CI, 2.23 to 3.61), respectively.

Conclusion LNR predicts survival after breast cancer more accurately than pN classification and should be considered as an alternative to pN staging.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JCOHome page
V. Van Belle, B. Van Calster, H. Wildiers, S. Van Huffel, and P. Neven
Lymph Node Ratio Better Predicts Disease-Free Survival in Node-Positive Breast Cancer Than the Number of Positive Lymph Nodes
J. Clin. Oncol., October 20, 2009; 27(30): e150 - e151.
[Full Text] [PDF]


Home page
JCOHome page
V. Vinh-Hung, H. M. Verkooijen, G. Fioretta, G. Vlastos, E. Rapiti, and C. Bouchardy
Reply to V. Van Belle et al
J. Clin. Oncol., October 20, 2009; 27(30): e152 - e152.
[Full Text] [PDF]


Home page
JCOHome page
K. M. Musallam, F. R. Jamali, H. A. Hatoum, M. Seoud, N. S. El-Saghir, and A. I. Shamseddine
Axillary Lymph Node Ratio Revisited
J. Clin. Oncol., August 20, 2009; 27(24): e67 - e67.
[Full Text] [PDF]


Home page
JCOHome page
V. Vinh-Hung, H. M. Verkooijen, G. Vlastos, G. Fioretta, I. Neyroud-Caspar, E. Rapiti, and C. Bouchardy
Reply to K.M. Musallam et al
J. Clin. Oncol., August 20, 2009; 27(24): e68 - e69.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online